Xu Zhi-Peng, Sun Hai-Xiang, Zhang Ning-Yuan
Center of Reproductive Medicine, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu 210008, China.
Zhonghua Nan Ke Xue. 2008 Mar;14(3):259-63.
With the introduction of assisted reproductive technology (ART), sperm assessment has developed progressively, from conventional semen routine tests to novel cellular and molecular measures. Sperm DNA damage is a new marker of male fertility, whose genetic mechanism involves abnormal package and segregation of chromatin, oxidative stress, abnormal cell apoptosis, etc. Sperm chromatin structure assay (SCSA) is one of the common techniques to measure sperm DNA damage. Sperm DNA damage might be associated with the pregnancy outcome of ART, recurrent spontaneous abortion and potential genetic risk of ICSI offspring. Some treatment strategies might reduce the percentage of sperm DNA damage and increase the success rate of ART, including oral administration of antioxygen drugs, ICSI with testis sperm, sperm freezing and preservation, removing of etiological factors, traditional Chinese medicine, and so on. This review focuses on the mechanism and detection of sperm DNA damage, its association with reproductive outcomes, and relevant treatment strategies in assisted reproductive technology.
随着辅助生殖技术(ART)的引入,精子评估已逐步发展,从传统的精液常规检测到新颖的细胞和分子检测方法。精子DNA损伤是男性生育能力的一个新指标,其遗传机制涉及染色质的异常包装和分离、氧化应激、细胞凋亡异常等。精子染色质结构分析(SCSA)是测量精子DNA损伤的常用技术之一。精子DNA损伤可能与ART的妊娠结局、复发性自然流产以及ICSI后代的潜在遗传风险有关。一些治疗策略可能会降低精子DNA损伤的百分比并提高ART的成功率,包括口服抗氧化药物、使用睾丸精子进行ICSI、精子冷冻保存、去除病因、中药等。本文综述聚焦于辅助生殖技术中精子DNA损伤的机制、检测、其与生殖结局的关联以及相关治疗策略。